Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

This publication has 16 references indexed in Scilit:

• beta Blockade after myocardial infarction: systematic review and meta regression analysis
  BMJ, 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
  New England Journal of Medicine, 1998
• National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction
  Published by American Medical Association (AMA) ,1998
• Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study fn1fn1This study was supported by a University-Industry grant from the Medical Research Council, Ottawa, Ontario, Canada and Bristol Myers Squibb, Montreal, Quebec, Canada.
  Journal of the American College of Cardiology, 1997
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction
  JAMA, 1982
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981